Matsui, Doris O.
U.S. Representative CA-6 Democratic PartyCongressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.
Latest disclosed trades
Latest 6 of 6| Ticker | Type | Traded |
|---|---|---|
| — U.S. Treasury Note due 05/31/202 | Buy | Sep 3, 2024 |
| — U.S. Treasury Note due 4/15/2024 | Buy | Apr 18, 2023 |
| — U.S. Treasury Note due 4/15/2023 | Buy | Mar 13, 2023 |
| NU | Buy | Jun 11, 2021 |
| — u.S. Treasury Note due 7/15/2021 | Sell | Dec 28, 2020 |
| — Westmed Holding Company F ILINg | Sell | Jun 29, 2017 |
Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.
Matsui, Doris O. stock trade activity
FilingIQ has indexed 6 congressional stock trade disclosures for Matsui, Doris O.. The most recent disclosed transaction is dated Sep 3, 2024.
Across the full history, 4 purchases and 2 sales have been disclosed under the STOCK Act.
Top tickers traded by Matsui, Doris O.
Frequently asked
- How many stock trades has Matsui, Doris O. disclosed?
- FilingIQ tracks 6 Periodic Transaction Report disclosures for Matsui, Doris O., with the most recent dated Sep 3, 2024. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
- Is Matsui, Doris O. a net buyer or net seller?
- Across the disclosed trade history, 4 (67%) were purchases and 2 (33%) were sales. Compensation and exchanges are filtered out of these counts.
- Where does FilingIQ's data on Matsui, Doris O. come from?
- Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.
Methodology & sources
Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.